GaviLAX 17 GM Powder for Oral Solution
- RxCUI
- 876214
- RxNorm name
- GaviLAX 17 GM Powder for Oral Solution
- Display name
- GaviLAX 17 GM Powder for Oral Solution
- Full name
- GaviLAX 17 GM Powder for Oral Solution
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:21
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GAVILAX | POLYETHYLENE GLYCOL 3350 | Atlantic Biologicals Corp. | 4c207478-6f0f-c3cf-e063-6394a90aa4f2 | 2026-06-04 | Warnings | 876214 |
| GAVILAX | POLYETHYLENE GLYCOL 3350 | Preferred Pharmaceuticals, Inc. | 21654def-5ae0-422d-961b-1fe2456af00a | 2026-05-04 | Warnings | 876214 |
| GAVILAX | POLYETHYLENE GLYCOL 3350 | Lupin Pharmaceuticals,Inc. | 19672e23-1606-497e-a112-939af33af195 | 2025-12-08 | Warnings | 876214 |
| GAVILAX | POLYETHYLENE GLYCOL 3350 | ATLANTIC BIOLOGICALS CORP. | c9688f06-b6db-4afb-b8ff-ef5fb8bf9946 | 2025-07-22 | Warnings | 876214 |
| GAVILAX | POLYETHYLENE GLYCOL 3350 | A-S Medication Solutions | 581baa4b-7331-47a3-81c6-680286f03aca | 2025-01-09 | Warnings | 876214 |
| GAVILAX | POLYETHYLENE GLYCOL 3350 | Proficient Rx LP | 199d6173-3fad-49e4-88fe-bde7223ed4c3 | 2022-06-01 | Warnings | 876214 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| c9688f06-b6db-4afb-b8ff-ef5fb8bf9946 | GaviLAX 17 GM Powder for Oral Solution | PSN | 14 | Gavilax Powder Solution Drug Facts | 20250722 |
| c9688f06-b6db-4afb-b8ff-ef5fb8bf9946 | Gavilax 17 GM Powder for Oral Solution | SY | 14 | Gavilax Powder Solution Drug Facts | 20250722 |
| c9688f06-b6db-4afb-b8ff-ef5fb8bf9946 | polyethylene glycol 3350 17000 MG Powder for Oral Solution [Gavilax] | SBD | 14 | Gavilax Powder Solution Drug Facts | 20250722 |
| 581baa4b-7331-47a3-81c6-680286f03aca | Gavilax 17 GM Powder for Oral Solution | SY | 9 | GAVILAX | 20250109 |
| 581baa4b-7331-47a3-81c6-680286f03aca | GaviLAX 17 GM Powder for Oral Solution | PSN | 9 | GAVILAX | 20250109 |
| 581baa4b-7331-47a3-81c6-680286f03aca | polyethylene glycol 3350 17000 MG Powder for Oral Solution [Gavilax] | SBD | 9 | GAVILAX | 20250109 |
| 19672e23-1606-497e-a112-939af33af195 | Gavilax 17 GM Powder for Oral Solution | SY | 8 | Drug Facts | 20251208 |
| 19672e23-1606-497e-a112-939af33af195 | polyethylene glycol 3350 17000 MG Powder for Oral Solution [Gavilax] | SBD | 8 | Drug Facts | 20251208 |
| 19672e23-1606-497e-a112-939af33af195 | GaviLAX 17 GM Powder for Oral Solution | PSN | 8 | Drug Facts | 20251208 |
| 21654def-5ae0-422d-961b-1fe2456af00a | GaviLAX 17 GM Powder for Oral Solution | PSN | 7 | Drug Facts | 20260504 |
| 21654def-5ae0-422d-961b-1fe2456af00a | polyethylene glycol 3350 17000 MG Powder for Oral Solution [Gavilax] | SBD | 7 | Drug Facts | 20260504 |
| 21654def-5ae0-422d-961b-1fe2456af00a | Gavilax 17 GM Powder for Oral Solution | SY | 7 | Drug Facts | 20260504 |
| 199d6173-3fad-49e4-88fe-bde7223ed4c3 | Gavilax 17 GM Powder for Oral Solution | SY | 6 | Drug Facts | 20220601 |
| 199d6173-3fad-49e4-88fe-bde7223ed4c3 | polyethylene glycol 3350 17000 MG Powder for Oral Solution [Gavilax] | SBD | 6 | Drug Facts | 20220601 |
| 199d6173-3fad-49e4-88fe-bde7223ed4c3 | GaviLAX 17 GM Powder for Oral Solution | PSN | 6 | Drug Facts | 20220601 |
| 4c207478-6f0f-c3cf-e063-6394a90aa4f2 | polyethylene glycol 3350 17000 MG Powder for Oral Solution [Gavilax] | SBD | 1 | Gavilax (Polyethylene Glycol 3350) | 20260303 |
| 4c207478-6f0f-c3cf-e063-6394a90aa4f2 | Gavilax 17 GM Powder for Oral Solution | SY | 1 | Gavilax (Polyethylene Glycol 3350) | 20260303 |
| 4c207478-6f0f-c3cf-e063-6394a90aa4f2 | GaviLAX 17 GM Powder for Oral Solution | PSN | 1 | Gavilax (Polyethylene Glycol 3350) | 20260303 |